Skip to main content
BI

Biosyntia

Hørsholm, Denmark
Last funding
$11.7M
Series BJul 2022

Biosyntia is a biotech startup within synthetic biology and metabolic engineering.

Backed byNovo HoldingsSofinnova PartnersEuropean Circular Bioeconomy FundNovo Ventures

About Biosyntia

How much funding has Biosyntia raised?

Biosyntia has raised $11.7M in total funding. The most recent round was Series B. The last funding was announced in July 2022.

Who are Biosyntia's investors?

Biosyntia's investors include Novo Holdings, Sofinnova Partners, European Circular Bioeconomy Fund, Novo Ventures.

Where is Biosyntia headquartered?

Biosyntia is headquartered in Hørsholm, Denmark.

What does Biosyntia do?

Biosyntia is a biotech startup within synthetic biology and metabolic engineering.

What stage is Biosyntia at?

Biosyntia is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Biosyntia — Funding & Investors." VCBacked, July 6, 2022, https://www.vcbacked.co/company/biosyntia. Accessed November 20, 2026.
APA
VCBacked. (2022). Biosyntia — Funding & Investors. Retrieved November 20, 2026, from https://www.vcbacked.co/company/biosyntia
Wikipedia (cite web)
{{cite web |title=Biosyntia — Funding & Investors |url=https://www.vcbacked.co/company/biosyntia |website=VCBacked |access-date=November 20, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Biosyntia? Request a listing update

Founder contacts
m***@biosyntia.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →